230 related articles for article (PubMed ID: 15150164)
1. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
Muller A; Lopez-Lozano JM; Bertrand X; Talon D
J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
[TBL] [Abstract][Full Text] [Related]
2. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
Bamberger DM; Dahl SL
Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
[TBL] [Abstract][Full Text] [Related]
3. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
[TBL] [Abstract][Full Text] [Related]
4. Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
Honderlick P; Saheb F; Cahen P
Pathol Biol (Paris); 1999 May; 47(5):437-9. PubMed ID: 10418014
[TBL] [Abstract][Full Text] [Related]
5. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G
Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641
[TBL] [Abstract][Full Text] [Related]
6. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
7. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
Foster DR; Rhoney DH
Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
[TBL] [Abstract][Full Text] [Related]
8. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
[TBL] [Abstract][Full Text] [Related]
9. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
10. Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime.
Grohs P; Kernéis S; Sabatier B; Lavollay M; Carbonnelle E; Rostane H; Souty C; Meyer G; Gutmann L; Mainardi JL
J Antimicrob Chemother; 2014 Mar; 69(3):786-9. PubMed ID: 24159154
[TBL] [Abstract][Full Text] [Related]
11. [Nosocomial colonization and infection by multiresistant Enterobacter cloacae strains on a pediatric oncological unit].
Ritter E; Thurm V; Bauernfeind A; Dorittke C; Völpel S; Finger H
Zentralbl Hyg Umweltmed; 1994 Aug; 196(1):81-94. PubMed ID: 7802900
[TBL] [Abstract][Full Text] [Related]
12. [Enterobacter cloacae epidemic on a neonatal intensive care unit due to the use of contaminated thermometers].
Donkers LE; van Furth AM; van der Zwet WC; Fetter WP; Roord JJ; Vandenbroucke-Grauls CM
Ned Tijdschr Geneeskd; 2001 Mar; 145(13):643-7. PubMed ID: 11305216
[TBL] [Abstract][Full Text] [Related]
13. [Resistance to third generation cephalosporins in Sfax hospitals, Tunisia (1999-2005)].
Mkaouar D; Mahjoubi F; Mezghani S; Znazen A; Ktari S; Hammami A
Med Mal Infect; 2008 Jun; 38(6):293-8. PubMed ID: 18191516
[TBL] [Abstract][Full Text] [Related]
14. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Berche P; Gaillard JL
Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
[TBL] [Abstract][Full Text] [Related]
16. [Detection of the new type of aminoglycoside acetyltransferase gene in Enterobacter cloacae isolates].
Xiong ZZ; Wang P; Wang ZX; Li J
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):422-4. PubMed ID: 18581900
[TBL] [Abstract][Full Text] [Related]
17. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.
Liu G; Ling BD; Zeng Y; Lin L; Xie YE; Lei J
Jpn J Infect Dis; 2008 Jul; 61(4):286-9. PubMed ID: 18653970
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Daikos GK
Chemioterapia; 1985 Feb; 4(1):43-6. PubMed ID: 3986944
[TBL] [Abstract][Full Text] [Related]
20. Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.
Kaneko K; Okamoto R; Nakano R; Kawakami S; Inoue M
J Clin Microbiol; 2005 Jun; 43(6):2955-8. PubMed ID: 15956430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
